Moreover, it was shown that Spry2 plays functionally important roles in HCC by inhibiting hepatocyte growth factor (HGF)-induced cell proliferation and ERK activation in the Spry2-overexpressing HCC cells. The gene discussed is HGF; the disease is hepatocellular carcinoma.